270 related articles for article (PubMed ID: 16923407)
1. RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
Van Gelder IC; Van Veldhuisen DJ; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Bosker HA; Cornel JH; Kamp O; Veeger NJ; Volbeda M; Rienstra M; Ranchor AV; TenVergert EM; Van den Berg MP
Am Heart J; 2006 Sep; 152(3):420-6. PubMed ID: 16923407
[TBL] [Abstract][Full Text] [Related]
2. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
Am Heart J; 2002 Oct; 144(4):597-607. PubMed ID: 12360154
[TBL] [Abstract][Full Text] [Related]
3. Lenient versus strict rate control in patients with atrial fibrillation.
Van Gelder IC; Groenveld HF; Crijns HJ; Tuininga YS; Tijssen JG; Alings AM; Hillege HL; Bergsma-Kadijk JA; Cornel JH; Kamp O; Tukkie R; Bosker HA; Van Veldhuisen DJ; Van den Berg MP;
N Engl J Med; 2010 Apr; 362(15):1363-73. PubMed ID: 20231232
[TBL] [Abstract][Full Text] [Related]
4. A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).
Shelton RJ; Clark AL; Goode K; Rigby AS; Houghton T; Kaye GC; Cleland JG
Heart; 2009 Jun; 95(11):924-30. PubMed ID: 19282313
[TBL] [Abstract][Full Text] [Related]
5. Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
Groenveld HF; Tijssen JG; Crijns HJ; Van den Berg MP; Hillege HL; Alings M; Van Veldhuisen DJ; Van Gelder IC;
J Am Coll Cardiol; 2013 Feb; 61(7):741-8. PubMed ID: 23410544
[TBL] [Abstract][Full Text] [Related]
6. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
Delnoy PP; Ottervanger JP; Luttikhuis HO; Elvan A; Misier AR; Beukema WP; van Hemel NM
Am J Cardiol; 2007 May; 99(9):1252-7. PubMed ID: 17478153
[TBL] [Abstract][Full Text] [Related]
7. ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).
Hohnloser SH; Capucci A; Fain E; Gold MR; van Gelder IC; Healey J; Israel CW; Lau CP; Morillo C; Connolly SJ;
Am Heart J; 2006 Sep; 152(3):442-7. PubMed ID: 16923410
[TBL] [Abstract][Full Text] [Related]
8. Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.
Van Gelder IC; Wyse DG; Chandler ML; Cooper HA; Olshansky B; Hagens VE; Crijns HJ;
Europace; 2006 Nov; 8(11):935-42. PubMed ID: 16973686
[TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
[TBL] [Abstract][Full Text] [Related]
10. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
Groenveld HF; Crijns HJ; Van den Berg MP; Van Sonderen E; Alings AM; Tijssen JG; Hillege HL; Tuininga YS; Van Veldhuisen DJ; Ranchor AV; Van Gelder IC;
J Am Coll Cardiol; 2011 Oct; 58(17):1795-803. PubMed ID: 21996393
[TBL] [Abstract][Full Text] [Related]
11. The Managed Ventricular pacing versus VVI 40 Pacing (MVP) Trial: clinical background, rationale, design, and implementation.
Sweeney MO; Ellenbogen KA; Miller EH; Sherfesee L; Sheldon T; Whellan D
J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1295-8. PubMed ID: 17081208
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of a randomized clinical trial to assess the role of overdrive and triggered prevention pacing therapies in reducing atrial fibrillation: the Study of Atrial Fibrillation Reduction (SAFARI).
Gold MR; Hoffmann E;
Am Heart J; 2006 Aug; 152(2):231-6. PubMed ID: 16875902
[TBL] [Abstract][Full Text] [Related]
13. Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
Groenveld HF; Crijns HJ; Rienstra M; Van den Berg MP; Van Veldhuisen DJ; Van Gelder IC;
Am Heart J; 2009 Nov; 158(5):785-91. PubMed ID: 19853699
[TBL] [Abstract][Full Text] [Related]
14. Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial.
Roy D
Card Electrophysiol Rev; 2003 Sep; 7(3):208-10. PubMed ID: 14739714
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation follow-up investigation of rhythm management -- the AFFIRM study design. The Planning and Steering Committees of the AFFIRM study for the NHLBI AFFIRM investigators.
Am J Cardiol; 1997 May; 79(9):1198-202. PubMed ID: 9164885
[TBL] [Abstract][Full Text] [Related]
16. Design and rationale of a randomized study to compare amiodarone and Class IC anti-arrhythmic drugs in terms of atrial fibrillation treatment efficacy in patients paced for sinus node disease: the PITAGORA trial.
Gulizia M; Mangiameli S; Chiarandà G; Spadola V; Di Giovanni N; Colletti A; Bulla V; Circo A; Pensabene O; Vasquez L; Vaccaro I; Grammatico A;
Europace; 2006 Apr; 8(4):302-5. PubMed ID: 16627459
[TBL] [Abstract][Full Text] [Related]
17. Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design.
Hamdan MH; Freedman RA; Gilbert EM; Dimarco JP; Ellenbogen KA; Page RL
Pacing Clin Electrophysiol; 2006 Oct; 29(10):1081-8. PubMed ID: 17038140
[TBL] [Abstract][Full Text] [Related]
18. Who, when and how to rate control for atrial fibrillation.
Rienstra M; Van Gelder IC
Curr Opin Cardiol; 2008 Jan; 23(1):23-7. PubMed ID: 18281823
[TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
Rienstra M; Van Veldhuisen DJ; Hagens VE; Ranchor AV; Veeger NJ; Crijns HJ; Van Gelder IC;
J Am Coll Cardiol; 2005 Oct; 46(7):1298-306. PubMed ID: 16198847
[TBL] [Abstract][Full Text] [Related]
20. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.
Mulder BA; Van Veldhuisen DJ; Crijns HJ; Tijssen JG; Hillege HL; Alings M; Rienstra M; Groenveld HF; Van den Berg MP; Van Gelder IC;
Eur J Heart Fail; 2013 Nov; 15(11):1311-8. PubMed ID: 23759284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
